Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
18 Junio 2009 - 9:00AM
PR Newswire (US)
- Candela's Vbeam Laser Gives Millions of Post-Surgical Patients a
New Sense of Freedom - WAYLAND, Mass., June 18
/PRNewswire-FirstCall/ -- Candela Corporation (NASDAQ:CLZR)
announced today that two studies have reported superior results on
patients who benefited from the Candela Vbeam(R) laser treatments
for bruising resulting from cosmetic procedures. The studies
concluded that the Vbeam pulsed-dye laser significantly expedited
the healing process, improved outcomes, and provided greater
overall patient satisfaction. To view the multimedia assets
associated with this release, please click
http://news.prnewswire.com/viewrelease.aspx?STORY=NzE= A study
published in the March/April 2009 edition of the Archives of Facial
Plastic Surgery, entitled: "Pulsed-Dye Laser for Treating
Ecchymoses After Facial Cosmetic Procedures" by DeFatta, R. J.,
Krishna, S., and Williams, E. F., III concluded that "the Vbeam
laser treatment resulted in a 63% mean improvement in ecchymoses
scores within forty-eight (48) to seventy-two (72) hours." The
second study, a 2009 ASLMS abstract, entitled: "A Simple Solution
to a Common Problem" evaluated the effectiveness and safety of the
long-pulse PDL (the Vbeam) for the treatment of ecchymoses. In this
study by Elizabeth Hale, M.D., Julie Karen, M.D., Chris Hunzeker,
M.D., Elliot Weiss, M.D., Leonard Bernstein, M.D., Lori Brightman,
M.D., Anne Chapas, M.D., and Roy Geronemus, M.D. results showed
that twenty-four hours post-treatment with the Vbeam laser, the
average improvement was 62% and 13% for treated and untreated
bruises, respectively. Edwin F. Williams, M.D., Director, The
Williams Center Plastic Surgery Specialists, and nationally
recognized plastic surgeon pioneered this breakthrough Vbeam
treatment. "Anytime you penetrate the skin there is a potential for
bruising and we find that it is the bruising which occurs after
many of these procedures that prevents patients from getting out
into the public. It is extremely difficult to cover these unsightly
marks with make-up and bruising can last for a number of weeks,"
said Dr. Williams. Dr. Williams continued, "After just one
treatment with the Vbeam, our patients experience dramatic
clearance of the injured blood vessels. This treatment is a
significant differentiator to our practice and we are excited to
finally be able to offer our patients a safe and easy treatment of
bruising that works!" Roy G. Geronemus, M.D., Director, Laser &
Skin Surgery Center of New York, commented, "There are millions of
surgical and injectable procedures performed every year which often
have bruising as a side effect that can last up to two weeks." Dr.
Geronemus continued, "This is a significant new use for the Vbeam
which was already our 'workhorse' laser because of its efficacy and
safety profile for a wide variety of applications including skin
rejuvenation, the treatment of rosacea, acne, diffuse redness,
scars and more." For more information and to request copies of the
studies, visit http://www.candelalaser.com/ or call 800-733-8550,
ext. 247. About CANDELA: Candela Corporation manufactures and
distributes innovative clinical solutions that enable physicians,
surgeons, and personal care practitioners to treat selected
cosmetic and medical conditions using lasers, aesthetic laser
systems, and other advanced technologies. Founded near Boston in
1970, Candela markets and services its products in 86 countries
from offices and distributors in the United States, Europe, Japan,
China and other Asian locations. Candela established the aesthetic
laser market 20 years ago, and currently has an installed base of
over 14,000 systems worldwide. To view the safe harbor statement
visit http://www.candelalaser.com/ Related Links treating
ecchymoses Vbeam
http://news.prnewswire.com/viewrelease.aspx?STORY=NzE=DATASOURCE:
Candela Corporation CONTACT: Jane Smith, +1-508-358-7400, ext. 247,
Web Site: http://www.candelalaser.com/
Copyright